Nasdaq: ORKA

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker ORKA. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
ORKA
Exchange
Nasdaq
SEC CIK
907654
Official filings
SEC EDGAR

Research ORKA

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Oruka Therapeutics, Inc.'s stock ticker?

Oruka Therapeutics, Inc. trades under the ticker symbol ORKA on Nasdaq. Its SEC Central Index Key (CIK) is 907654.

Where can I read Oruka Therapeutics, Inc.'s SEC filings?

The ORKA SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Oruka Therapeutics, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze ORKA's financial statements?

The ORKA Financials page shows Oruka Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does ORKA compare with its peers and the market?

The ORKA Peer Comparison page lines Oruka Therapeutics, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.